BRCA1 and BRCA2 mutations in breast cancer patients from Venezuela

Biological Research

Volumn 45, Issue 2, 2012, Pages 117-130

  Lara, Karlena ^a   Consigliere, Nigmet ^a   Pérez, Jorge ^b   Porco, Antonietta ^a  

^a UNIVERSIDAD SIMÓN BOLÍVAR   (Venezuela)

^b Centro Clinico de Estereotaxia   (Venezuela)

Author keywords

BRCA genes; Breast cancer; Screening mutations

Indexed keywords

EID: 84866135226     PISSN: 07169760     EISSN: 07176287     Source Type: Journal    
DOI: 10.4067/S0716-97602012000200003     Document Type: Article

References (35)

1. ALBÁNEZ S, RUIZ-SAEZ A, BOADAS A, DE BOSCH N, PORCO A (2011) Identification of factor VIII gene mutations in patients with severe haemophilia A in Venezuela: identification of seven novel mutations. Haemophilia 17: e913-e918
2. BOWEN DJ, KEENEY S (2003) Unleashing the long-distance PCR for detection of the intron 22 inversion of the factor VIII gene in severe haemophilia A. Thromb Haemost 89: 201-2.
3. BROSE MS, VOLPE P, PAUL K, STOPFER JE, COLLIGON TA, CALZONE KA, WEBER BL (2004) Characterization of two novel BRCA1 germ-line mutations involving splice donor sites. Genet Test 8: 133-8.
4. CAPOTE L (2006) Aspectos epidemiológicos del cáncer en Venezuela. Rev venez oncol 18: 269-281.
5. CHAPPUIS PO, NETHERCOT V, FOULKES WD (2000) Clinico-pathological characteristics of BRCA1-and RCA2-related breast cancer. Semin Surg Oncol 18:287-95.
6. DEN DUNNEN JT, ANTONARAKIS SE (2001) Nomenclature for the description of human sequence variations. Hum Genet 109: 121-4.
7. DUFLOTH MR, CARVALHO S, HEINRICH JK, SHINZATO JY, CABELLO DOS SANTOS C, SCHMITT F, ZEFERINO LC (2005) Analysis of BRCA1 and BRCA2 mutations in Brazilian breast cancer patients with positive family history. Sao Paulo Med J 123:192-197.
8. FORD D, EASTON DF, STRATTON M, NAROD S, GOLDGAR D, DEVILEE P, BISHOP DT, WEBER B, LENOIR G, CHANG-CLAUDE J, SOBOL H, TEARE MD, STRUEWING J, ARASON A, SCHERNECK S, PETO J, REBBECK TR, TONIN P, NEUHAUSEN S, BARKARDOTTIR R, EYFJORD J, LYNCH H, PONDER BA, GAYTHER SA, ZELADAHEDMAN M AND THE BREAST CANCER LINKAGE CONSORTIUM (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62: 676-89.
9. FRIEDMAN LS, OSTERMEYER EA, SZABO CI, DOWD P, LYNCH ED, ROWELL SE, KING MC (1994) Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 8: 399-404.
10. GALLARDO M, SILVA A, RUBIO L, ALVAREZ C, TORREALBA C, SALINAS M, TAPIA T, FAUNDEZ P, PALMA L, RICCIO ME, PAREDES H, RODRIGUEZ M, CRUZ A, ROUSSEAU C, KING MC, CAMUS M, ALVAREZ M, CARVALLO P (2006) Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations. Breast Cancer Res and Treat 95:81-87.
11. GANGULY A, ROCK MJ, PROCKOP DJ (1993) Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in doublestranded PCR products and DNA fragments: evidence for solventinduced bends in DNA heteroduplexes. Proc Natl Acad Sci U S A 90: 10325-9.
12. GANGULY A, LEAHY K, MARSHALL AM, DHULIPALA R, GODMILOW L, GANGULY T (1997) Genetic testing for breast cancer susceptibility: frequency of BRCA1 and BRCA2 mutations. Genet Test 1:85-90.
13. GOMES M, COSTA M, BOROJEVIC R, MONTEIRO A, VIEIRA R, KOIFMAN S, JORGE KOIFMAN R, LI S, ROYER R, ZHANG S, NAROD S (2007) Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil. Breast Cancer Res Treat 103:349-353.
14. HONRADO E, BENÍTEZ J, PALACIOS J (2005) The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications. Mod Pathol 18: 1305-20.
15. JARA L, AMPUERO S, SANTIBÁÑEZ E, SECCIA L, RODRÍGUEZ J, BUSTAMANTE M, MARTÍNEZ V, CATENACCIO A, LAY-SON G, BLANCO R, REYES JM. (2006) BRCA1 and BRCA2 mutations in a South American population. Cancer Genet Cytogenet 166:36-45.
16. KING MC, MARKS JH, MANDELL JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302: 643-6.
17. KOJIC M, HOLLOMAN WK (2004) BRCA2-RAD51-DSS1 interplay examined from a microbial perspective. Cell Cycle 3: 247-8.
18. KUPERSTEIN G, FOULKES WD, GHADIRIAN P, HAKIMI J, NAROD SA (2000) A rapid fluorescent multiplexed-PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genes. Clin Genet 57: 213-20.
19. LAKHANI SR, VAN DE VIJVER MJ, JACQUEMIER J, ANDERSON TJ, OSIN PP, MCGUFFOG L, EASTON DF (2002) The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20:2310-2318.
20. MCCARTHY EE, CELEBI JT, BAER R, LUDWIG T (2003) Loss of Bard1, the heterodimeric partner of the Brca1 tumor suppressor, results in early embryonic lethality and chromosomal instability. Mol Cell Biol 23: 5056-63.
21. MIKI Y, SWENSEN J, SHATTUCK-EIDENS D, FUTREAL PA, HARSHMAN K, TAVTIGIAN S, LIU Q, COCHRAN C, BENNETT LM, DING W ET AL. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71.
22. MITCHELL A (2002) DNA repair: molecular mimicry. Nat Rev Cancer 2894: 1-5.
23. OZCELIK H, NEDELCU R, CHAN VW, SHI XH, MURPHY J, ROSEN B, ANDRULIS IL (1999) Mutation in the coding region of the BRCA1 gene leads to aberrant splicing of the transcript. Hum Mutat 14: 540-1.
24. REID LJ, SHAKYA R, MODI AP, LOKSHIN M, CHENG JT, JASIN M, BAER R, LUDWIG T (2008) E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks. Proc Natl Acad Sci U S A 105: 20876-81.
25. RODRÍGUEZ-LARRALDE A, CASTRO DE GUERRA D, GONZALEZ-COIRA M, MORALES J (2001) Frecuencia génica y porcentaje de mezcla en diferentes áreas geográficas de Venezuela, de acuerdo a los grupos RH y ABO. Interciencia 26: 8-12.
26. RUIZ-FLORES P, SINILNIKOVA O, BADZIOCH M, CALDERON-GARCIDUEÑAS AL, CHOPIN S, FABRICE O, GONZÁLEZGUERRERO JF, SZABO C, LENOIR G, GOLDGAR D, BARRERASALDAÑA H (2002) BRCA1 and BRCA2 Mutation Analysis of Early-Onset and Familial Breast Cancer Cases in Mexico. Hum Mutat 20:474-475.
27. SALGADO J, GIL C, ROBLES M, GUTIÉRREZ C, REYNA C, GARCÍAFONCILLAS J (2008) A characterization of genetic haplotypes in BRCA1 identifies linkage disequilibrium with novel polymorphism in intron 7. Gene Ther Mol Biol 12: 175-180.
28. SARKAR G, YOON HS, SOMMER S (1992) Screening for mutations by RNA single-strand conformation polymorphism (rSSCP): comparison with DNA-SSCP. Nucleic Acids Res 20:871-878.
29. SHAPIRO MB, SENAPATHY P (1987) RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res 15: 7155-74.
30. TESORIERO AA, WONG EM, JENKINS MA, HOPPER JL, BROWN MA, CHENEVIX-TRENCH G, SPURDLE AB, SOUTHEY MC (2005) Molecular characterization and cancer risk associated with BRCA1 and BRCA2 splice site variants identified in multiple-case breast cancer families. Hum Mutat 26: 495.
31. TORRES D, RASHID MU, GIL F, UMANA A, RAMELLI G, ROBLEDO JF, TAWIL M, TORREGROSA L, BRICENO I, HAMANN U. (2007). High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia. Breast Cancer Res Treat 103:225-232.
32. WARNER E, FOULKES W, GOODWIN P, MESCHINO W, BLONDAL J, PATERSON C, OZCELIK H, GOSS P, ALLINGHAM-HAWKINS D, HAMEL N, DI PROSPERO L, CONTIGA V, SERRUYA C, KLEIN M, MOSLEHI R, HONEYFORD J, LIEDE A, GLENDON G, BRUNET JS, NAROD S (1999) Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Inst 91: 1241-7.
33. WOOSTER R, BIGNELL G, LANCASTER J, SWIFT S, SEAL S, MANGION J, COLLINS N, GREGORY S, GUMBS C, MICKLEM G (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789-92.
34. WOOSTER R, NEUHAUSEN SL, MANGION J, QUIRK Y, FORD D, COLLINS N, NGUYEN K, SEAL S, TRAN T, AVERILL D ET AL. (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265: 2088-90.
35. YANG H, JEFFREY PD, MILLER J, KINNUCAN E, SUN Y, THOMA NH, ZHENG N, CHEN PL, LEE WH, PAVLETICH NP (2002) BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science 297: 1837-48.